Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.

While fasting plasma insulin levels tended to be lower in the tpl2 −/− mice, this difference did not reach statistical significance ( Figure 3B ).

also in 111,027 other papers